S21-461 Cell-type specific enzymatic degradation of pathological mucins Targeted protein degradation is an emerging strategy for the elimination of classically undruggable proteins. Mucins are known to be involved in tumor-progressive pathways but are difficult to target using small molecules and antibodies. Carolyn Bertozzi Kayvon Pedram Dayeon Shon Gabrielle Tender
S20-364 New Immunotherapeutic Target for the Treatment of Lung Cancer and Fibrotic Lung Diseases Stanford scientists have discovered a new immunotherapeutic target for treating lung cancer and fibrotic lung disease. Gerlinde Wernig Tristan Lerbs Lu Cui Qiwen Deng Cristabelle De Souza